66 filings
Page 3 of 4
1-A
lea2i0 rtw
18 Nov 21
Offering $12M in Equity
12:44pm
D/A
ijxzk1uoa 480476b
12 Oct 21
$9M in equity, sold $5.52M, 42 investors
7:52am
8-K
0o1hwv42
1 Oct 21
Termination of a Material Definitive Agreement
12:00am
8-K
grvd u3qrac03uif
27 Aug 21
Termination of a Material Definitive Agreement
12:00am
8-K
6p3jp
19 Aug 21
Coeptis Therapeutics Partners with VyGen-Bio, Inc. to Co-develop Two Assets
12:53pm
D/A
wryn3my6o7yhmveiav15
28 Jul 21
$6M in equity, sold $5.21M, 39 investors
11:34am
8-K
teensskt6ijj8
13 Jul 21
New Corporate Name and Updated Stock Ticker Symbol Highlight Company’s Brand Transformation
2:36pm
10-KT
797e7crezlogqeow
11 May 21
Annual report (with FYE transition)
4:48pm
8-K
4ry7pxo 6bh
11 May 21
Entry into a Material Definitive Agreement
2:20pm
8-K/A
tmnymp9ry4qqmlikjf
10 May 21
Completion of Acquisition or Disposition of Assets
7:47am
8-K
r5iejy
30 Apr 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:19pm
D
7ci nz9gzfux
24 Mar 21
$6M in equity, sold $171K, 2 investors
11:21am
D
bkzqmvpr3f3emb08cfh
25 Feb 21
$0 in equity, 81 investors
12:03pm
8-K
u7hwdu q3dsk
12 Feb 21
Entry into a Material Definitive Agreement
12:51pm
8-K
qvg ii9s6
4 Jan 21
Entry into a Material Definitive Agreement
3:03pm